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Abstract
Background—Lead (Pb) exposure has been associated with poorer cognitive function cross-
sectionally in aging adults, however the association between cumulative Pb exposure and 
longitudinal changes in cognition is little characterized.
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Methods—In a 1993–2007 subcohort of the VA Normative Aging Study (Mini-mental status 
exam (MMSE) n=741; global cognition summary score n=715), we used linear mixed effects 
models to test associations between cumulative Pb exposure (patella or tibia bone Pb) and repeated 
measures of cognition (MMSE, individual cognitive tests, and global cognition summary). Cox 
proportional hazard modeling assessed the risk of an MMSE score falling below 25.
Results—Among men 51–98 at baseline, higher patella Pb concentration (IQR: 21 µg/g) was 
associated with −0.13 lower baseline MMSE (95% CI: −0.25, −0.004) and faster longitudinal 
MMSE decline (−0.016 units/year, 95% CI: −0.032, −0.0004) over 15 years. Each IQR increase in 
patella Pb was associated with increased risk of a MMSE score below 25 (HR=1.21, 95% CI: 0.99, 
1.49; p=0.07). There were no significant associations between Pb and global cognition (both 
baseline and longitudinal change). Patella Pb was associated with faster longitudinal decline in 
Word List Total Recall in the language domain (0.014 units/year, 95% CI: −0.026, −0.001) and 
Word List Delayed Recall in the memory domain (0.014 units/year, 95% CI: −0.027, −0.002). We 
found weaker associations with tibia Pb.
Conclusions—Cumulative Pb exposure is associated with faster declines in MMSE and Word 
List Total and Delayed Recall tests. These findings support the hypothesis that Pb exposure 
accelerates cognitive aging.
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Introduction
Approximately 13 percent of the US population is aged 65 and older, and that demographic 
is expected to reach 19 percent by 2030,1 leading to increased numbers of older adults 
susceptible to cognitive impairment and neurodegenerative diseases.2,3 Worldwide, an 
estimated 35.6 million people were living with dementia in 2010, and this figure is expected 
to nearly double by 2030.4 Cognitive impairment is part of a spectrum that deviates from 
normal aging, eventually leading to dementia. Dementia and mild cognitive impairment are 
associated with reductions in memory, visuospatial, orientation, and language domains.
Exposure to lead (Pb) adversely affects cognition, independent of age-related cognitive 
decline. In adults, Pb exposure from occupational or environmental sources has been 
inversely associated with scores on the Mini Mental Status Exam (MMSE).5–8 Patella Pb 
was associated with declines in scores on the MMSE,9 as well as measures of visuospatial 
and visuomotor ability,10 indicating that a mobilized, accumulated Pb burden may impact 
cognition.11 Prior research has only measured changes in MMSE or other cognitive tests 
over two visits. In most cognitive aging studies, mean MMSE score increases between first 
and second repeat tests, attributed in part to a learning effect, where subjects recognize 
questions from previous tests.12,13
This study evaluated the associations between long-term Pb exposure and longitudinal 
changes in cognition repeatedly measured at up to five visits over 15 years. As such, the 
learning effect can be accounted for over more tests per subject. Our hypothesis is that 
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cumulative Pb exposure as measured by bone Pb is associated with accelerated cognitive 
decline over 15 years, and we tested this by evaluating the following cognitive function 




This research was conducted on a subgroup of the VA Normative Aging Study, which is a 
longitudinal cohort established in Massachusetts in 1963.14 Healthy men (n=2,280), between 
the ages of 21–80, were recruited and participated in clinical examination and complete 
health and lifestyle questionnaires every 3 to 5 years depending on the age at each exam 
(every 5 years before age of 50 years and every 3 years after 50 years). At enrollment, men 
were excluded from the study if they had a past or present history of heart disease, cancer, 
diabetes, gout, asthma, sinusitis, bronchitis, peptic ulcer, or blood pressure greater than 
140/90 mm Hg. Starting in 1993, 1131 men underwent a battery of tests to assess cognitive 
function (described below).
From 1991 until 1999, 876 participants had bone Pb measurements. The overlap of subjects 
with both patella and tibia bone lead measurement and cognitive measurement included 795 
subjects. We further excluded subjects who had a patella Pb or tibia Pb measure with 
uncertainty greater than 15 µg/g (n=2) or 10 µg/g (n=6), respectively, and this yielded 788 
subjects. Measurements with high uncertainty in bone Pb usually indicate excessive subject 
movement during measurement.15 These 788 subjects contributed to a total of 2,397 
cognitive function tests from 1993 through 2011. For the MMSE analysis, we excluded 
subjects who did not have an MMSE score (n=43), yielding 776 subjects and 2,245 
observations. Finally, we excluded subjects with missing data on covariates: education level 
(n=30 subjects), and alcohol intake (n=8 subjects). This yielded a final number of 741 
subjects with at least one MMSE assessment and full covariate data for the MMSE analysis. 
The sixth (n=20) and seventh assessments (n=1) for MMSE were dropped to account for 
influential outliers, resulting in 2,132 total observations for the 741 subjects (average 
number of repeated measurements=3.04; average elapsed time between cognitive tests=3.80 
years (SD=1.57) (see details of study sample selection procedures in Supplementary Figure 
S1).
Because longitudinal regression models are subject to the learning effect in MMSE tests, we 
examined the binary outcome of MMSE score less than 25 at any time point after baseline 
using a cox proportional hazards model. In this analysis, we excluded 80 subjects with 
baseline MMSE scores less than 25 or 167 with only one MMSE test result. This resulted in 
521 total subjects at baseline (Supplementary Figure S1).
A similar exclusion based on missing data for covariates of interest yielded 715 subjects 
(n=1,410 observations) with at least one measure of a global cognitive index (described 
below). Here, the fourth assessment was dropped to account for influential outliers, resulting 
in 1,365 total observations for the 715 subjects analyzed for changes in global cognition.
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Bone lead was measured using K-shell X-ray fluorescence (KXRF) spectroscopy as 
previously described.10 Briefly, 109Cd gamma rays excite the K-shell electrons of Pb 
embedded in bone, which emit an X-ray photon that can then be detected. An ABIOMED 
KXRF Instrument was used to measure lead at the tibia and the patella, corresponding to 
cortical and trabecular bone, respectively. The KXRF beam collimator was directed 
perpendicular to the tibial midshaft and at a 30° angle from the horizontal for the patella for 
30-minute measures.10,16–18
Cognitive assessments
Several cognitive assessments were used for this analysis: the MMSE, NES2 
(Neurobehavioral Evaluation System 2),19 CERAD (Consortium to Establish a Registry for 
Alzheimer’s Disease),20 and WAIS-R (Wechsler Adult Intelligence Scale-Revised).21 The 
MMSE assesses overall cognition by testing several domains including memory, visuospatial 
ability, attention, language, and orientation. Validated in multiple populations, the MMSE is 
widely used as a screening test for dementia,22 and to assess cognitive decline in non-
demented populations.23 Declines of the MMSE over time may indicate underlying 
pathologies such as Alzheimer’s disease, where the MMSE declines by an average of 1.8–
4.2 points per year,24–26 or normal cognitive declines associated with aging. The MMSE 
includes 30 questions, but the present analysis did not include “Which County are we in?” 
because counties in Massachusetts do not have political meaning. Thus, the maximum score 
was 29
We also assessed scores from 7 individual tests used in the NES2, CERAD, or WAIS-R, 
which have been described elsewhere.6,27,28 Two of the tests, word list total recall and verbal 
fluency (both CERAD), are generally associated with language. The digit span backward 
sum test (WAIS-R), total number recalled for digit span test (WAIS-R), and word list 
delayed recall test (CERAD) assess memory. The pattern recognition test (NES2) and visual 
drawings summary score (CERAD) assess visuospatial ability. In addition to assessing each 
of these tests individually, we calculated a summary score of these tests, referred to as 
“global cognition”, which we tested as a separate proxy for worsening cognitive impairment. 
To standardize comparisons in creating the summary score, we calculated z-scores for each 
test by subtracting the observed value for any subject at any time from the mean baseline 
cognitive score, and divided that value by the standard deviation of the baseline cognitive 
score. Overall global cognition was assessed by average z-scores of 6 of the tests (total 
number recalled for digit span backward was excluded due to similarity with digit span 
backward sum).
Other Covariates
We included age at first cognitive test, past education level and baseline smoking status, and 
alcohol intake as covariates in our regression model. Smoking status was assessed by 
questionnaire and subjects were re-categorized as “current smokers”, “had smoked in the 
past and quit”, or “had never smoked”. Alcohol intake was assessed by whether a person had 
more than two alcoholic beverages per day. Subjects were categorized as not having finished 
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high school (<12 years), those who were high school graduates or completed some college 
(12–15 years), and college graduates (>16 years).
Data Analysis
The data used in this study were managed using SAS software (version 9.4 for Windows) 
and all analyses were performed using R Software version 3.1.0. We used mean and standard 
deviation univariate descriptive statistics to characterize our study population. We further 
calculated the Pearson correlation between z-score measures of cognitive domains to 
understand the relationships between tests. We summarized the sample size and mean values 
of global scores at each visit.
We used linear mixed effects models to assess the association between baseline Pb exposure 
and longitudinal changes, separately in each of the measures of cognition described above. 
This approach is robust in the analysis of unbalanced data. Our baseline model included 
baseline patella Pb, time from first visit, the interaction of Pb and time, and baseline 
covariates (age, alcohol intake, smoking, and education). Linear mixed effects modeling 
allows for differences in the number of repeated measures across a subject’s visits. Our 
linear mixed effects model included random intercepts for individual as well as random 
slopes for time in order to account for correlations among the repeated measurements.
To account for the learning effects with MMSE and global cognition, we ran a second 
model, referred to as the First-test indicator model, that was the same as the basic model, 




This model, similar to one employed in prior studies30 can partially account for the learning 
effect by separating the change from visit 1 to visit 2, and regressing based on longitudinal 
changes from subsequent visits. Because MMSE is susceptible to a learning effect, as we 
observed in our study, we chose to report analyses based on the first-test indicator model.
Additionally, MMSE has a ceiling effect due to unequal interval scaling and may not be best 
modeled linearly. Ceiling effects may attenuate or inflate effect estimates in longitudinal 
analyses.31 Thus, we also ran a Cox proportional hazards model in which the dichotomous 
outcome was whether or not a patient dropped below a cutoff score of 25 on the MMSE 
assessment at any point during follow-up. The longitudinal analyses of individual tests and 
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summary measure of global cognition were reported from the basic model only. The cutoff 
for MMSE score to define mild cognitive impairment or dementia has varied across the vast 
literature using this cognitive test.32 Additionally, other studies have shown that people with 
a score of 24 or 25 are at risk for developing dementia.33
We chose to use the Cox model in order to conceptualize the issue as a time-to-event 
outcome. We are interested in the time to the first instance of crossing the threshold between 
cognitively normal and not cognitively normal. There are some unique situations where one 
might see true cognitive improvement (e.g. correction of a B vitamin deficiency) and 
measurement error makes the trajectory of cognitive scores slightly more variable. However, 
for most individuals, cognition will decline with time, with some individuals experiencing 
steep enough decline that they will cross the threshold into cognitive impairment. We tested 
the Cox proportional hazards assumption of all the predictors in the model by calculating 
Pearson product-moment correlation between the scaled Schoenfeld residuals and time for 
each covariate, and calculating a global P-value for all interactions of such a test calculated 
at once. Global p-value for the patella Pb model was p=0.50, and for tibia Pb model was 
p=0.38. These p-values suggest that the global proportionality assumption for Cox PH 
modeling was not violated. The individual variable for alcohol consumption seemed to 
violate the PH assumption, but the results remained unchanged when it was treated as strata. 
Supplementary table S1 demonstrates the number of subjects that dropped below a cutoff 
MMSE score of 25 after each visit.
The longitudinal analyses of individual tests and summary measure of global cognition were 
reported from the basic model only. Since there are seven individual domain measures and 
two global measures (MMSE and global cognition) for each of the two lead exposures (tibia 
and patella) it is important to consider multiple testing. Conservative Bonferroni correction 
across 18 tests would require a minimum p-value < 0.0028.
We performed several sensitivity analyses to test the robustness of our findings. First, there 
is a possibility for a selection bias related to health factors driving cohort participation in 
general and also the exclusion criteria at initial NAS recruitment34. In order to minimize 
this, we excluded subjects who were greater than 45 years of age at the time of NAS study 
enrollment because people over 45 would be more likely to exhibit health symptoms that 
would keep them out of the NAS and thus be more susceptible to these selection pressures. 
We also repeated our analyses with additional covariates including the history of a diagnosis 
of either hypertension, stroke, coronary artery disease, as those might be potential 




Among the 741 men with MMSE scores, mean patella Pb concentration was 30.6 µg/g 
(SD=19.4) and tibia Pb was 21.6 µg/g (SD=13.3) (Table 1). The average participant age was 
67.8 (SD=6.8) at the time of the first cognitive assessment (range, 51.4–98.0 years). The 
mean MMSE score for all subjects at visit 2 was 0.4 points higher than that at visit 1, 
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suggestive of a learning effect (Table 2). However, we observed a subsequent decline of 0.6 
points in mean scores from visit 2 to visit 5. There was a negligible increase in the z-score 
measure of global cognition between visits 1 and 2, and a decrease in the mean z-score by 
visit 3. Measures of individual cognitive domains at visit 1 were generally correlated and are 
reported in Supplementary Figure S2.
Lead Concentrations and Longitudinal Changes in MMSE
At baseline, an interquartile range (IQR) higher level of patella Pb (21 µg/g) was associated 
with 0.128 points lower MMSE score (95% confidence interval (CI): −0.251, −0.004; 
p=0.04) (Table 3). As expected, MMSE scores display an overall decline with time. There 
was a 0.10 point decrease in MMSE score per year (95% CI: −0.122, −0.077; p<0.0001). We 
observed a significant interaction between time and patella Pb on MMSE, indicating faster 
declines in MMSE scores as patella Pb levels increase. On average, MMSE scores were 
0.016 points lower per IQR increase in baseline patella Pb per year of follow-up (95% CI: 
−0.032, −0.0004; p=0.04). This suggests that over 10 years of follow-up, MMSE scores are 
expected to drop by 0.16 points more per IQR increase in baseline patella Pb. We found 
similar but weaker associations with tibia Pb (Table 3).
Associations between Lead Concentrations and risk of having an MMSE score below 25
An IQR increase in patella Pb was borderline significantly associated with increased risk of 
having an MMSE score dip below the cutoff of 25 (hazard ratio (HR)=1.21, 95% CI: 0.99, 
1.49; p = 0.07) (Table 4). The same analysis done with tibia Pb yields a non-significant 
association with MMSE score (HR=1.05, 95% CI: 0.82, 1.35).
Associations between Lead Concentrations and Global Cognition
At baseline, each IQR increase in patella Pb was borderline significantly associated with a 
0.25 points lower global cognition Z-score (95% CI: −0.518, 0.019; p=0.07) (Table 5). 
However, the interaction between patella Pb and time was not significantly associated with 
global cognition Z-score. Again, we found similar but weaker associations with tibia Pb 
(Table 5).
Associations between Lead Concentrations and Cognitive Domains
The trajectories of each cognitive test score varied by domain (language, memory, 
visuospatial) (Table 6). In the language domain, there was a significant interaction between 
time and patella Pb on word list total recall. There was also a 0.014 point decrease in the 
word list total recall z-score for every IQR increase in patella Pb per year of follow-up (95% 
CI: −0.026, −0.001; p=0.04). The word list delayed recall test, a similar test in the memory 
domain, had a similar result. An IQR increase in patella Pb was associated with 0.014 point 
decrease in word-list delayed recall per year of follow-up (95% CI: −0.027, −0.002; p=0.03). 
All associations failed to reach significance when considering the conservative multiple 
testing corrected p-value threshold (p<0.0028). There were no associations between changes 
in language or memory domain tests and the interaction between tibia Pb and time of follow-
up.
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In the visuospatial domain, the baseline mean visual drawings summary score was 
associated with a 0.108 point decrease (95% CI: −0.185, −0.031) for every IQR increase in 
patella Pb. However, no significant positive interaction between patella Pb and time was 
observed on pattern recognition scores or visual drawings summary score. Tibia Pb was 
significantly inversely associated with baseline level but positively associated with the rate 
of change in visual drawing summary z-score. Every IQR increase in tibia Pb was associated 
with a 0.142 points lower visual drawing z-score at baseline (95% CI: −0.227, −0.057) and a 
0.016 point increase per year change in time (95% CI: 0.001, 0.031) in the visual drawing 
summary z-score (Supplementary Figure S3).
Sensitivity Analyses
Our sensitivity analyses yielded similar results for the parameters of interest 
(βTime Of Follow Up, βPb, βPb*Time Of Follow Up) found in the primary analysis. This was true 
for the analysis in which we excluded subjects who were >45 years of age at enrollment as 
well as the analysis in which we accounted for history of hypertension, stroke, coronary 
artery disease.
Discussion
We have further characterized the association between cognition and bone Pb over time in a 
15-year subcohort of the NAS. Our data shows that faster longitudinal decline in MMSE 
score is associated with higher bone Pb levels, and the rate becomes steeper with time, 
which is consistent with previous literature. As shown in table 2, MMSE scores slightly rose 
from visit 1 to 2 (on average), but then declined. The decline in MMSE scores from visits 2 
to 5 was consistent with trends observed previously in the NAS.9
A strength of the present study is the use of Pb measured in both cortical and trabecular 
bone, corresponding to the tibia and patella. These sites were chosen because of their 
differences in half-life. Reports on the half-life of Pb in bone vary by site as well as with 
factors such as age, prior exposure, and other conditions that modify bone turnover. 
Trabecular bone is reported to have an elimination half-life (t1/2) of 8–20 years.16,35 Cortical 
bone has a much longer half-life, with estimates ranging from 10–48.6 years.16,18,35 Tibia 
bone Pb measures may be interpreted as the cumulative lead exposure in our population, 
whereas patella bone Pb serves as the predominant bone that provides Pb from bone 
resorption back to circulation35. This may explain why, in our analyses, patella Pb had a 
more statistically significant association with MMSE scores relative to tibia Pb.
In order to contextualize the magnitude of effect of Pb, we can compare the effect estimates 
for Pb to known aging risk factors for cognitive decline. For example, the magnitude of 
association between an IQR increase in patella Pb and MMSE score at baseline was −0.13 
(95% CI: −0.25, −0.004), even greater than the per-year decline in MMSE (−0.10 points; 
95% CI: −0.12, −0.077). Further, patella Pb exposure was associated with a more rapid rate 
of annual decline, as seen by the interaction term of βPb*Time Of Follow Up. The association 
between a 21 µg/g higher patella lead and annual change in MMSE score was 0.016 point/
year. Given the widespread and cumulative nature of lead exposure, even those small 
associations, if causal, have large population attributable risk.
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Each individual cognitive test can be assigned to a domain of cognition, although 
performance on each test often involves cognitive processes from multiple domains. In our 
analysis, the language domain included word list total recall and verbal fluency; the memory 
domain included digit span backward sum, total number recalled for digit span, and word list 
delayed recall; and the visuospatial domain included pattern recognition and visual drawings 
summary score. Age has varying effects on different domains and tests of cognition. For 
example, the individual tests of cognition that decline with age, when measured separately, 
have parameter estimates for βTime Of Follow Up that are 13–40% smaller in magnitude 
relative to the same parameter estimates found using global cognition measures, suggesting 
that aging may have a cumulative effect on overall cognition rather than each individual test.
Our findings regarding the effect of Pb on cognition are consistent with other studies. It has 
been established that cross-sectional cognitive test scores vary negatively with bone 
Pb.6,7,9,36 Additionally, in the NAS, change in cognition was measured by the difference in 
MMSE scores between the first two visits only.9 Although the previous study did not 
incorporate as many as five visits, it nonetheless observed a significant association between 
increasing Pb and decreasing MMSE (one-IQR higher patella Pb concentration associated 
with −0.24 point change in MMSE), which was about 1.5 times the magnitude of what was 
found in our present study. Our data add to these findings by assessing longitudinal repeated 
measures over 15 years rather than 3–4 years. The decline of scores over this longer period 
of time is larger than the practice effect, allowing for effective modeling. Other studies of 
longitudinal change in cognition have noted similar trends as well.11,30,37 Clinical treatment 
for pre-clinical declines in cognition would be strengthened by effective biomarkers of 
dementia; this expanding area of research could also lead to longitudinal testing 
improvements in epidemiologic risk factor identification.38–40
Additionally, we noted that several individual cognitive test scores (word list recall, both 
delayed and total) decreased faster with higher exposure to Pb. Although we did observe a 
positive interaction between time and tibia Pb in our visual drawings score, the main effect 
of time and the main effect of Pb are still inversely associated with MMSE. As shown in 
supplementary figure S3, the declining MMSE trajectory for visual drawings has a steeper 
slope for a lower IQR of tibia Pb. This would paradoxically suggest that higher tibia Pb has a 
correcting effect on MMSE. However, this may be due to the fact that tibia Pb is more of a 
measure of cumulative exposure. Future studies that include repeat measures of Pb exposure 
would help clarify this relationship. Overall, the visuospatial and language domain had 
significant associations with either tibia or patella Pb and time, or the interaction of Pb and 
time.
It is not appropriate to convert MMSE scores to Z-scores because they are more prone to 
non-linear change. In other words, a decrease from an MMSE score of 28 to 27 is much less 
severe than a decrease from 25 to 24. Thus, we also performed a separate logistic regression 
analysis of MMSE scores that takes into account the non-continuous nature of the variable. 
Our results from that analysis supported the findings of the linear mixed effects analysis. 
The results of the longitudinal model suggest that the trajectory of MMSE scores over time 
will vary depending on Pb exposure (Table 3). The logistic analysis supplements this 
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finding, suggesting that patella Pb exposure may be associated with a clinically important 
shift in cognition.
Our study also has the possibility for selection bias due to loss to follow up. Loss to follow 
up may be related to comorbidities associated with Pb exposure. The subjects lost to follow-
up may also have had cognitive decline that is associated with Pb exposure, but would not be 
included in the final analysis. In results not shown, neither patella Pb nor tibia Pb was 
associated with number of follow-up visits. Our sensitivity analysis excluding people with 
less than three visits did not affect parameter estimates. We recognize this as a limitation of 
our study. However, a dropout bias would skew results towards the null, so a correction for 
dropout bias would further support the hypothesis that Pb exposure worsens longitudinal 
cognitive decline. A more sophisticated analysis, such as marginal structural models with 
inverse probability weighting34 may be useful to better understand this potential dropout 
bias. Additionally, although there were substantial correlations among the separate tests in 
the study, our decision to model each outcome in separate models resulted in not taking 
correlation or covariance structure of the various outcomes into account.
The major strength of our study is that it employs longitudinal data from up to five visits 
over 15 years, allowing us to observe changes in cognition over time. Additionally, bone Pb 
is a well-established biomarker of long-term Pb exposure. Our data employ both tibia and 
patella bone Pb measurements, allowing us to assess the effect of varying measures of long-
term Pb exposure. Although a number of subjects have migrated over the 50 years of the 
study, the NAS cohort was originally selected from men have lived in a relatively 
homogeneous geographic area, allowing us to adjust for known confounders and mitigating 
the effect of unknown confounders. We used longitudinal models to measure the association 
of an important toxicant with changes in cognition over time. Such models can be used for 
future purposes to assess the role of interaction amongst exposures or between gene and 
environment over time.
In conclusion, we identified an association between baseline Pb and rate of change in 
cognition over time, spanning several measures of cognition, including MMSE. These 
findings further support the hypothesis that cumulative lead exposure may accelerate 
cognitive aging. Our results have implications for aging populations with historical Pb 
exposures, even when current exposure levels are low.
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• Cognitive data collected over 15 years was used to study how lead 
affects cognitive trajectories.
• Cumulative exposure to lead as measured by bone lead levels was 
associated with faster decline in mini-mental status exam scores.
• This suggests that exposure to lead accelerates cognitive aging, and 
possibly functional status.
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Table 1
Baseline Study Characteristics – VA Normative Aging Study. Boston, Massachusetts.
MMSE Global Cognition
Number of Subjects 741 715
Mean Age in years (SD) 67.77 ± 6.82 68.43 ± 7.11
Mean Patella Pb in µg/g
(SD)
30.64 ± 19.44 30.47 ± 19.65
Mean Tibia Pb in µg/g
(SD)
21.62 ± 13.33 21.39 ± 13.31
Education in number of
years (%)
  <12 33 (4.4) 33 (4.6)
  12–15 yrs 555 (74.9) 532 (74.4)
  16+ 153 (20.6) 150 (21.0)
Smoking Status (%)
  Never 221 (29.8) 209 (29.2)
  Former 47 (6.3) 44 (6.2)
  Current 473 (63.8) 462 (64.6)
More than 2 alcoholic
beverages per day? (%)
  No 585 (78.9) 560 (78.3)
  Yes 156 (21.1) 152 (21.3)
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Table 2
Mean Cognition Scores over time






1 741 26.9 ± 1.4 715 1.5*10−6 ± 3.6
2 574 27.1 ± 1.6 452 0.0096 ± 3.8
3 415 26.7 ± 1.8 198 −0.12 ± 3.8
4 273 26.7 ± 1.8
5 129 26.5 ± 2.0
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Table 3
Association between Pb and MMSE over time (n=741)
Patella Pb
  Parameter β-Estimate Confidence Interval p-value
IQR change in Pb −0.128 (−0.251, −0.004) 0.04
Time −0.100 (−0.122, −0.077) <0.0001
IQR change in Pb*time −0.016 (−0.032, −0.0004) 0.04
Tibia Pb
  Parameter β-Estimate Confidence Interval p-value
IQR change in Pb −0.077 (−0.206, 0.052) 0.15
Time −0.099 (−0.122, −0.077) <0.0001
IQR change in Pb*time −0.011 (−0.028, 0.005) 0.19
Each exposure (patella or tibia) was included as a predictor in a separate model. Covariates were baseline age, smoking status, education level, and 
alcohol consumption. Interpretation of parameters: Pb – baseline association of IQR change in patella Pb and MMSE; Time – change in MMSE for 
every IQR increase in Pb per year change in time; Pb*Time – change in MMSE for every IQR increase in Pb per year change in time. The IQR for 
patella Pb was 21 µg/g and for tibia Pb was 15 µg/g.
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Table 4
Cox-proportional HR of having MMSE score drop below 25 in association with an IQR increase in Bone Pb 
Levels (n=521)
HR 95% CI
Patella Pb (IQR=21 µg/g) 1.21 (0.99, 1.49)
Tibia Pb (IQR=15 µ/g) 1.05 (0.82, 1.35)
Adjusted for baseline age, smoking status, education level, and alcohol consumption.
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Table 5
Association of Pb and Global Cognition over time (n=715)
Patella Pb
  Parameter β-Estimate Confidence Interval p-value
IQR change in Pb −0.250 (−0.518, 0.019) 0.07
Time −0.147 (−0.187, −0.107) <0.0001
IQR change in Pb*time −0.027 (−0.069, 0.014) 0.20
Tibia Pb
  Parameter β-Estimate Confidence Interval p-value
IQR change in Pb −0.206 (−0.453, 0.089) 0.16
Time −0.148 (−0.184, −0.106) <0.0001
IQR change in Pb*time 0.002 (−0.040, 0.038) 0.93
This was modeled similarly as regression shown in Table 3. Models were adjusted for baseline age, smoking status, education level, and alcohol 
consumption. Global cognition was created as the average of the sum of z-scores of 6 of the individual tests.
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